Next Article in Journal / Special Issue
Evaluation of Tissue Interactions with Mechanical Elements of a Transscleral Drug Delivery Device
Previous Article in Journal
Preparation and Characterization of Amino Acids-Based Trimethoprim Salts
Pharmaceutics 2012, 4(1), 197-211; doi:10.3390/pharmaceutics4010197

Ocular Drug Delivery for Glaucoma Management

1, 2, 1, 3, 3, 3 and 3,*
1 Department of Bioengineering, University of Utah, Salt Lake City, UT, USA 2 Department of Pharmacy, University of Utah, Salt Lake City, UT, USA 3 Moran Eye Center, University of Utah, Salt Lake City, UT, USA
* Author to whom correspondence should be addressed.
Received: 22 December 2011 / Revised: 6 February 2012 / Accepted: 1 March 2012 / Published: 8 March 2012
(This article belongs to the Special Issue Ocular Drug Delivery)
View Full-Text   |   Download PDF [175 KB, uploaded 8 March 2012]


Current glaucoma management modalities are hindered by low patient compliance and adherence. This can be due to highly complex treatment strategies or poor patient understanding. Treatments focus on the management or reduction of intraocular pressure. This is most commonly done through the use of daily topical eye drops. Unfortunately, despite effective therapies, glaucoma continues to progress, possibly due to patients not adhering to their treatments. In order to mitigate these patient compliance issues, many sustained release treatments are being researched and are entering the clinic. Conjunctival, subconjunctival, and intravitreal inserts, punctal plugs, and drug depots are currently in clinical development. Each delivery system has hurdles, yet shows promise and could potentially mitigate the current problems associated with poor patient compliance.
Keywords: glaucoma; IOP; drug delivery; sustained release; polymer; inserts; punctal plug glaucoma; IOP; drug delivery; sustained release; polymer; inserts; punctal plug
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
MDPI and ACS Style

Gooch, N.; Molokhia, S.A.; Condie, R.; Burr, R.M.; Archer, B.; Ambati, B.K.; Wirostko, B. Ocular Drug Delivery for Glaucoma Management. Pharmaceutics 2012, 4, 197-211.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


Cited By

[Return to top]
Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert